Glimepiride
Glimepiride is a pharmaceutical drug with 139 clinical trials. Historical success rate of 86.0%.
Success Metrics
Based on 104 completed trials
Phase Distribution
Phase Distribution
9
Early Stage
11
Mid Stage
105
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
83.2%
104 of 125 finished
16.8%
21 ended early
0
trials recruiting
139
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Evaluate the Renal Protective Effect (Urine Albumin-to-Creatinine Ratio (UACR)), Efficacy and Safety of Ipragliflozin in Type 2 Diabetes Mellitus Patients With Albuminuria
Effect of Sodium-glucose Cotransporter-2 Inhibitor in Cellular Senescence in Patients With Cardiovascular Diseases or Type 2 Diabetes
Omega 3 Fatty Acids on Serum Irisin and Sirtuin-1 in Type 2 Diabetic Mellitus Patients Treated With Glimepiride
Replication of the GRADE Diabetes Trial in Healthcare Claims Data
Replication of the LEAD-2 Diabetes Trial in Healthcare Claims Data
Clinical Trials (139)
A Study to Evaluate the Renal Protective Effect (Urine Albumin-to-Creatinine Ratio (UACR)), Efficacy and Safety of Ipragliflozin in Type 2 Diabetes Mellitus Patients With Albuminuria
Effect of Sodium-glucose Cotransporter-2 Inhibitor in Cellular Senescence in Patients With Cardiovascular Diseases or Type 2 Diabetes
Omega 3 Fatty Acids on Serum Irisin and Sirtuin-1 in Type 2 Diabetic Mellitus Patients Treated With Glimepiride
Replication of the GRADE Diabetes Trial in Healthcare Claims Data
Replication of the LEAD-2 Diabetes Trial in Healthcare Claims Data
Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes
Effect of Gemigliptin Versus Glimepiride on Cardiac Diastolic Function in Patients With Type 2 Diabetes
The Effects of Glimepiride in Patients With Type 2 Diabetes and Chronic Heart Failure
Bioequivalence Study of 3 mg Glimepiride Tablet in Indonesia Healthy Subjects
Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass
The Effect of Glimepiride Compared With Sitagliptin as an add-on Therapy to Metformin in Severe Insulin Deficiency Diabetes
Interaction of Bexagliflozin With Metformin, Glimepiride and Sitagliptin
SGLT2 Inhibitor Versus Sulfonylurea on Type 2 Diabetes With NAFLD
Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
Efficacy and Safety of Sotagliflozin Versus Glimepiride and Placebo in Participants With Type 2 Diabetes Mellitus That Are Taking Metformin Monotherapy
Vildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 Diabetes
Glimepiride, Alogliptin and Alogliptin+Pioglitazone Combination
Dapagliflozin and Measures of Cardiovascular Autonomic Function in Patients With Type 2 Diabetes (T2D)
Effect of Sodium Glucose Co-transporter 2 Inhibitor on Inflammatory Cytokine in Type 2 Diabetes
A 52-week International, Multicenter Trial With a Long -Term Extension to Evaluate Saxagliptin With Dapagliflozin in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 139